Literature DB >> 20127125

Screening for recombinant human erythropoietin using [Hb], reticulocytes, the OFF(hr score), OFF(z score) and Hb(z score): status of the Blood Passport.

Andreas Bornø1, Niels J Aachmann-Andersen, Thor Munch-Andersen, Carl J Hulston, Carsten Lundby.   

Abstract

Haemoglobin concentration ([Hb]), reticulocyte percentage (retic%) and OFF(hr score) are well-implemented screening tools to determine potential recombinant human erythropoietin (rHuEpo) abuse in athletes. Recently, the International Cycling Union implemented the OFF(z score) and the Hb(z score) in their anti-doping testing programme. The aim of this study is to evaluate the sensitivity of these indirect screening methods. Twenty-four human subjects divided into three groups with eight subjects each (G1; G2 and G3) were injected with rHuEpo. G1 and G2 received rHuEpo for a 4-week period with 2 weeks of "boosting" followed by 2 weeks of "maintenance" and a wash-out period of 3 weeks. G3 received rHuEpo for a 10-week period (boost = 3 weeks; maintenance = 7 weeks; wash out = 1 week). Three, seven and eight of the 24 volunteers exceeded the cut-off limits for OFF(hr score), [Hb] and retic%, respectively. One subject from G1, nobody from G2, and seven subjects from G3 exceeded the cut-off limit for Hb(z score.) In total, ten subjects exceeded the cut-off limit for the OFF(z score); two subjects from G1, two subjects from G2 and six subjects from G3. In total, indirect screening methods were able to indicate rHuEpo injections in 58% of subjects. However, 42% of our rHuEpo-injected subjects were not detected. It should be emphasised that the test frequency in real world anti-doping is far less than the present study, and hence the detection rate will be lower.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127125     DOI: 10.1007/s00421-010-1370-5

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  18 in total

1.  A global strategy for prevention and detection of blood doping with erythropoietin and related drugs.

Authors:  M Cazzola
Journal:  Haematologica       Date:  2000-06       Impact factor: 9.941

2.  The effects of microdose recombinant human erythropoietin regimens in athletes.

Authors:  Michael Ashenden; Emmanuelle Varlet-Marie; Françoise Lasne; Michel Audran
Journal:  Haematologica       Date:  2006-07-25       Impact factor: 9.941

3.  Erythropoietin and blood doping.

Authors:  N Robinson; S Giraud; C Saudan; N Baume; L Avois; P Mangin; M Saugy
Journal:  Br J Sports Med       Date:  2006-07       Impact factor: 13.800

4.  Prolonged administration of recombinant human erythropoietin increases submaximal performance more than maximal aerobic capacity.

Authors:  J J Thomsen; R L Rentsch; P Robach; J A L Calbet; R Boushel; P Rasmussen; C Juel; C Lundby
Journal:  Eur J Appl Physiol       Date:  2007-08-01       Impact factor: 3.078

5.  Testing for recombinant human erythropoietin in urine: problems associated with current anti-doping testing.

Authors:  Carsten Lundby; Niels J Achman-Andersen; Jonas J Thomsen; Anne M Norgaard; Paul Robach
Journal:  J Appl Physiol (1985)       Date:  2008-06-26

6.  Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume.

Authors:  Carsten Lundby; Jonas Juhl Thomsen; Robert Boushel; Maria Koskolou; Jørgen Warberg; José A L Calbet; Paul Robach
Journal:  J Physiol       Date:  2006-11-09       Impact factor: 5.182

7.  Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?

Authors:  C Lundby; P Robach; R Boushel; J J Thomsen; P Rasmussen; M Koskolou; J A L Calbet
Journal:  J Appl Physiol (1985)       Date:  2008-06-05

8.  Stability of hemoglobin mass over 100 days in active men.

Authors:  Annette Eastwood; Will G Hopkins; Pitre C Bourdon; Robert T Withers; Christopher J Gore
Journal:  J Appl Physiol (1985)       Date:  2008-01-24

9.  False-positive detection of recombinant human erythropoietin in urine following strenuous physical exercise.

Authors:  Monique Beullens; Joris R Delanghe; Mathieu Bollen
Journal:  Blood       Date:  2006-02-21       Impact factor: 22.113

Review 10.  Importance of hemoglobin concentration to exercise: acute manipulations.

Authors:  José A L Calbet; Carsten Lundby; Maria Koskolou; Robert Boushel
Journal:  Respir Physiol Neurobiol       Date:  2006-03-03       Impact factor: 1.931

View more
  10 in total

Review 1.  The evolving science of detection of 'blood doping'.

Authors:  Carsten Lundby; Paul Robach; Bengt Saltin
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Preanalytical variability: the dark side of the moon in blood doping screening.

Authors:  Giuseppe Lippi; Giuseppe Banfi; Nicola Maffulli
Journal:  Eur J Appl Physiol       Date:  2010-03-24       Impact factor: 3.078

3.  Early effects of erythropoietin on serum hepcidin and serum iron bioavailability in healthy volunteers.

Authors:  Fabrice Lainé; Bruno Laviolle; Martine Ropert; Guillaume Bouguen; Jeff Morcet; Catherine Hamon; Catherine Massart; Mark Westermann; Yves Deugnier; Olivier Loréal
Journal:  Eur J Appl Physiol       Date:  2011-08-05       Impact factor: 3.078

4.  Sports doping: Racing just to keep up.

Authors:  Ewen Callaway
Journal:  Nature       Date:  2011-07-15       Impact factor: 49.962

5.  Novel serum biomarkers for erythropoietin use in humans: a proteomic approach.

Authors:  Britt Christensen; Lucila Sackmann-Sala; Diana Cruz-Topete; Jens Otto L Jørgensen; Niels Jessen; Carsten Lundby; John J Kopchick
Journal:  J Appl Physiol (1985)       Date:  2010-10-21

6.  Current markers of the Athlete Blood Passport do not flag microdose EPO doping.

Authors:  Michael Ashenden; Clare E Gough; Andrew Garnham; Christopher J Gore; Ken Sharpe
Journal:  Eur J Appl Physiol       Date:  2011-02-20       Impact factor: 3.078

Review 7.  Altitude and Erythropoietin: Comparative Evaluation of Their Impact on Key Parameters of the Athlete Biological Passport: A Review.

Authors:  Jonas J Saugy; Tania Schmoutz; Francesco Botrè
Journal:  Front Sports Act Living       Date:  2022-06-30

8.  Recombinant erythropoietin in humans has a prolonged effect on circulating erythropoietin isoform distribution.

Authors:  Niels Jacob Aachmann-Andersen; Søren Just Christensen; Kristian Lisbjerg; Peter Oturai; Anne-Kristine Meinild-Lundby; Niels-Henrik Holstein-Rathlou; Carsten Lundby; Niels Vidiendal Olsen
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

9.  Effects of glycerol and creatine hyperhydration on doping-relevant blood parameters.

Authors:  Thelma P Polyviou; Chris Easton; Lukas Beis; Dalia Malkova; Pantazis Takas; Catherine Hambly; John R Speakman; Karsten Koehler; Yannis P Pitsiladis
Journal:  Nutrients       Date:  2012-08-31       Impact factor: 5.717

Review 10.  The Specificities of Elite Female Athletes: A Multidisciplinary Approach.

Authors:  Carole Castanier; Valérie Bougault; Caroline Teulier; Christelle Jaffré; Sandrine Schiano-Lomoriello; Nancy Vibarel-Rebot; Aude Villemain; Nathalie Rieth; Christine Le-Scanff; Corinne Buisson; Katia Collomp
Journal:  Life (Basel)       Date:  2021-06-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.